These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5199396)

  • 21. [Deterioration of drugs in compounding studied by thin-layer chromatography. 2].
    Nakano K
    Iryo; 1969 Nov; 23(11):1441-5. PubMed ID: 5370266
    [No Abstract]   [Full Text] [Related]  

  • 22. Bulk compounding technology.
    Am J Hosp Pharm; 1968 Jun; 25(6):320. PubMed ID: 5656779
    [No Abstract]   [Full Text] [Related]  

  • 23. Predicting pharmaceutical incompatibilities of parenteral medications.
    Carlin HS; Perkins AJ
    Am J Hosp Pharm; 1968 Jun; 25(6):270-9. PubMed ID: 5656772
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of deterioration of compounded drugs by thin-layer chromatography].
    Nakano H
    Iryo; 1970 Jul; 24(7):577-84. PubMed ID: 5458298
    [No Abstract]   [Full Text] [Related]  

  • 25. The compatibility and stability of midazolam and dexamethasone in infusion solutions.
    Good PD; Schneider JJ; Ravenscroft PJ
    J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous therapy. 6. Compatibilities of drug additives.
    Williams JT; Moravec DF
    Hosp Manage; 1966 Jun; 101(6):43-4. PubMed ID: 5932207
    [No Abstract]   [Full Text] [Related]  

  • 27. Stability issues of parenteral chemotherapy drugs.
    de Lemos ML; Hamata L
    J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous admixture incompatibility.
    Donn R
    Am J Nurs; 1971 Feb; 71(2):325. PubMed ID: 5203610
    [No Abstract]   [Full Text] [Related]  

  • 29. Particulate matter in parenteral solutions.
    Med Lett Drugs Ther; 1968 May; 10(11):42-4. PubMed ID: 5656614
    [No Abstract]   [Full Text] [Related]  

  • 30. Designing a parenteral manufacturing facility.
    Goddard KR
    Bull Parenter Drug Assoc; 1969; 23(2):69-77. PubMed ID: 5776421
    [No Abstract]   [Full Text] [Related]  

  • 31. Facility for small volume parenteral manufacturing.
    Kelly PC
    Bull Parenter Drug Assoc; 1976; 30(2):72-9. PubMed ID: 949564
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous therapy. 7. Admixtures of drugs.
    Williams JT; Moravec DF
    Hosp Manage; 1966 Jul; 102(1):61-2. PubMed ID: 5938724
    [No Abstract]   [Full Text] [Related]  

  • 33. Mixing additives in plastic LVPs.
    Deardorff DL; Schmidt CN
    Am J Hosp Pharm; 1980 Dec; 37(12):1610, 1613. PubMed ID: 7446534
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug incompatibility from the standpoint of the intravenous route of drug administration.
    Williams JT
    Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems with infusion mixtures in health departments].
    Malý J; Samková M
    Zdrav Prac; 1975 Oct; 25(10):597-600. PubMed ID: 1045763
    [No Abstract]   [Full Text] [Related]  

  • 36. I. V. additive program belongs in the pharmacy.
    Brown RG
    Hospitals; 1969 Sep; 43(18):92-8. PubMed ID: 5809375
    [No Abstract]   [Full Text] [Related]  

  • 37. Recommendations to pharmacists for solving problems with large-volume parenterals-1979. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1980 May; 37(5):663-7. PubMed ID: 7386474
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspects of current parenteral formulation.
    Scheindlin S
    Bull Parenter Drug Assoc; 1970; 24(1):31-9. PubMed ID: 5415610
    [No Abstract]   [Full Text] [Related]  

  • 39. [Quality control of infusion solutions. I. Foreign particles in infusion solutions].
    van den Bemd AA
    Pharm Weekbl; 1969 Sep; 104(39):1205-9. PubMed ID: 5345140
    [No Abstract]   [Full Text] [Related]  

  • 40. Stability of dobutamine hydrochloride in selected large-volume parenterals.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Piltz GW; Goldberg RJ; Cutie AJ
    Am J Hosp Pharm; 1982 Nov; 39(11):1923-5. PubMed ID: 7148861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.